Compound Detail
CHEMBL435395
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL435395 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CJPUZWBNOFWOCC-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
308.4
MW (Da)
2.51
ALogP
4
HBA
0
HBD
57.7
PSA (Ų)
0.86
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 5.57
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 5.57 | 5.57 | 2700.0 | 1 |
| MT4 CHEMBL388 | EC50 | 5.57 | 5.57 | 2700.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MT4 | EC50 | = | 2700.0 | nM | 5.57 | Dose required to achieve 50% protection of MT-4 cells from HIV-1(IIIB) induced c... | 9767646 |
| Human immunodeficiency virus 1 | EC50 | = | 2700.0 | nM | 5.57 | Antiviral activity against Human immunodeficiency virus 1 infected human MT4 cel... | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 9767646 | 10.1021/jm9802012 | MT4 | 2 |
| 9767646 | 10.1021/jm9802012 | Human immunodeficiency virus 1 | 1 |
| - | 10.1007/s00044-008-9145-9 | Human immunodeficiency virus 1 | 1 |
Data from ChEMBL 36 via Core Engine